The practical answer
Evaluate clarity and stability in the complete intended formulation, not only in water. Define the magnesium input, ingredient mass, pH target, processing sequence, package and observation times. A clear fresh beaker does not establish a stable commercial beverage or prove preserved chelation in solution.
Define the product before testing the ingredient
Specify whether the concept is a conventional beverage or a liquid dietary supplement. FDA guidance explains that the classification depends on the product and its presentation, not simply on adding a mineral or choosing a Supplement Facts panel. Ingredient permissions and labeling need review for the intended use. [1]
For the laboratory brief, record the finished serving volume, elemental magnesium contribution, full base formulation and expected process. Include acids, flavors, sweeteners, other minerals and any solids that may affect observations. Do not request a universal “soluble” verdict without stating concentration and conditions.
Run a controlled comparison
The appropriate pH, mixing conditions and storage schedule are formulation-specific. A screening plan should be agreed with the development team; this article does not prescribe a universal pH window or thermal treatment for magnesium glycinate. Record observations in a form another person can reproduce.
- Prepare a base-formula control without the magnesium ingredient and a matched prototype with the intended input.
- Record water source, addition order, mixing, temperature history and pH using defined measurement procedures.
- Compare candidates at the same elemental contribution while also recording their different total ingredient masses.
- Evaluate the intended process and a justified range of realistic manufacturing variation rather than one favorable condition.
- Retain labeled samples in the proposed package for planned follow-up observations.
Track more than initial appearance
A visually clear solution may still require analytical and microbiological evaluation. Conversely, an intentionally opaque product may tolerate dispersed material but still require consistent distribution. Agree acceptance criteria around the product concept rather than treating transparency itself as a universal quality measure.
| Observation | Decision it supports |
|---|---|
| Clarity or turbidity | Whether the visual target is met under a defined measurement |
| Sediment and redispersibility | Whether settling changes appearance or dose distribution |
| pH over time | Whether the measured system remains within the development target |
| Taste and mouthfeel | Whether the complete formula meets sensory expectations |
| Assay and relevant quality tests | Whether appearance aligns with compositional and quality requirements |
On smaller screens, scroll the table horizontally.
Decide what the screen proves
Sensory profiling can support structured comparison of a prototype with a control or reference product. It should distinguish an observed attribute from an overall preference; an internal team liking a sample does not establish consumer acceptance. [2]
A successful screen supports the next development stage. It does not establish commercial shelf life, microbial safety, a clinical benefit or a quantitative chelation claim after dissolution. Take the selected formulation into an appropriate pilot and stability program, and retain the exact ingredient lot, specification and trial conditions so later changes can be assessed against a meaningful baseline.
Sources & further reading
- FDA: Distinguishing liquid dietary supplements from beverages
- ISO 13299:2016: Establishing a sensory profile, official abstract